Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Boucher

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Open Forum Infectious Diseases|February 23, 2023
Characterization of a Novel Pathogen in Immunocompromised Patients: <i>Elizabethkingia anophelis</i>-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase InhibitorsMohamad Yasmin, Laura J Rojas, Steven H Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure InfectionsKatherine N Sutton, Emily Lydon, Abigail Rader, et al.
Journal of Environmental Management|January 5, 2023
Confronting a post-pandemic new-normal-threats and opportunities to trust-based relationships in natural resource science and managementA M Muir, J R Bernhardt, N W Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract InfectionsDaniel J Minter, Tsai-Wei Wang, Abigail Rader, et al.
International Journal of Immunopathology and Pharmacology|June 3, 2004
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activitiesD Kempuraj, J Donelan, S Frydas, et al.
Open Forum Infectious Diseases|March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 StudyMichelle L Brown, Johann Motsch, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2011
Combating antimicrobial resistance: policy recommendations to save lives, Brad Spellberg, Martin Blaser, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Interleukin-17: a revisited studyS H Huang, S Frydas, P Conti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B Doernberg, Thomas P Lodise, Joshua T Thaden, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Open Forum Infectious Diseases|February 23, 2023
Characterization of a Novel Pathogen in Immunocompromised Patients: <i>Elizabethkingia anophelis</i>-Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase InhibitorsMohamad Yasmin, Laura J Rojas, Steven H Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure InfectionsKatherine N Sutton, Emily Lydon, Abigail Rader, et al.
Journal of Environmental Management|January 5, 2023
Confronting a post-pandemic new-normal-threats and opportunities to trust-based relationships in natural resource science and managementA M Muir, J R Bernhardt, N W Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract InfectionsDaniel J Minter, Tsai-Wei Wang, Abigail Rader, et al.
International Journal of Immunopathology and Pharmacology|June 3, 2004
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activitiesD Kempuraj, J Donelan, S Frydas, et al.
Open Forum Infectious Diseases|March 11, 2020
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 StudyMichelle L Brown, Johann Motsch, Keith S Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2011
Combating antimicrobial resistance: policy recommendations to save lives, Brad Spellberg, Martin Blaser, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Interleukin-17: a revisited studyS H Huang, S Frydas, P Conti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership GroupSarah B Doernberg, Thomas P Lodise, Joshua T Thaden, et al.
Pageof 18